Journal of Urologic Oncology

Search

Page Path

Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study: Minsu Choi, Teak Jun Shin, Byung Hoon Kim, Chun Il Kim, Kyung Seop Lee, Seock Hwan Choi, Hyun Tae Kim, Tae-Hwan Kim, Tae Gyun Kwon, Young Hwii Ko, Yoon Soo Hah, Jae-Shin Park, Se Yun Kwon; Korean J Urol Oncol. 2022;20(2):115-122. Published online May 26, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.2.115; Full text PubReader ePub PDF

Impact of Multiple Prostate Biopsies: Risk of Perioperative Complications and Biochemical Recurrence After Radical Prostatectomy: Kyong Min Park, Jae-Wook Chung, Jun-Koo Kang, Teak Jun Shin, Se Yun Kwon, Hyun Chan Jang, Yun-Sok Ha, Seock Hwan Choi, Wonho Jung, Jun Nyung Lee, Byung Hoon Kim, Bum Soo Kim, Hyun Tae Kim, Jae Soo Kim, Tae-Hwan Kim, Eun Sang Yoo, Kyung Seop Lee, Chun Il Kim, Sung Kwang Chung, Tae Gyun Kwon; Korean J Urol Oncol. 2020;18(1):24-31. Published online April 29, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.1.24; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

6,025	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,499	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
5,006	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,841	Complex Epidemiology of Prostate Cancer in Asian Countries
4,692	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com